SCHEDULE 13D/AAccepted Jul 10, 7:03 PM ET
BridgeBio Pharma, Inc. SCHEDULE 13D/A
Accepted (ET)
7:03 PM
Jul 10, 2026
Filed
Jul 10, 2026
Documents
2
Size
43.8 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.